Antimicrobial and biofilm inhibiting diketopiperazines

Current Medicinal Chemistry

Volumn 19, Issue 21, 2012, Pages 3564-3577

  De Carvalho, M P ^a   Abraham, W R ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

Antimicrobials; Antivirals; Biofilm inhibitors; Cyclic dipeptides; Diketopiperazines; Fungicides; Quorum quenchers

Indexed keywords

2,3,5A,6 TETRAHYDRO 6 HYDROXY 3 HYDROXYMETHYL 2 METHYL 3,10A BIS(METHYLTHIO)PYRAZINO[1,2 A]INDOLE 1,4 DIONE; 3 BENZYL 6 ISOBUTYLIDENE DIKETOPIPERAZINE; 3 BENZYLIDENE 6 ISOBUTYL DIKETOPIPERAZINE; ACETYLARANOTIN; ACETYLGLIOTOXIN; ALTERNAROSIN A; ANTIBIOTIC AGENT; AURANTIAMINE; BACILLUSAMIDE; BICOZAMYCIN; CHAETOMIN; CHETOCIN; COLLETOPIPERAZINE; CYCLO(GLYCYL L TYROSYL) 4,4 DIMETHYLALLYL ETHER; DIDEHYDRO DIKETOPIPERAZINE ALBONOURSIN; ECHINULINE; ENT CYCLOECHINULIN; ETZIONIN; GANCIDIN W; GLIOTOXIN; MACTANAMIDE; N,N' DIMETHYLEPIDITHIADIKETOPIPERAZINE; NOVOAMAUROMINE; PIPERAZINEDIONE; PRE AURANTIAMINE; SIRODESMIN PL; TRANSCRIPTION FACTOR LUXR; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERTICILLIN B; VIRIDAMINE;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTIPROTOZOAL ACTIVITY; ANTIVIRAL ACTIVITY; BIOFILM; NONHUMAN; QUORUM SENSING; REVIEW;

EID: 84863735130     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712801323243     Document Type: Review

References (137)

1. Sammes, P. G. Naturally occurring 2, 5-dioxopiperazines and related compounds. Fortschr. Chem. Org. Naturst., 1975, 32, 51-118.
2. Fenical, W. Chemical studies of marine bacteria: developing a new resource. Chem. Rev., 1993, 93, 1673-1683.
3. nd, J. H.; Singleton, F. L. A marine Micrococcus produces metabolites ascribed to the sponge Tedania ignis. Experientia, 1988, 44, 1021.
4. De Rosa, S.; Mitova, M.; Tommonaro, G. Marine bacteria associated with sponge as source of cyclic peptides. Biomol. Eng., 2003, 20, 311-316.
5. Bugni, T. S.; Ireland, C. M. Marine-derived fungi: a chemically and biologically diverse group of microorganisms. Nat. Prod. Rep., 2004, 21, 143-163.
6. Huang, R.; Zhou, X.; Xu T.; Yang, X.; Liu, Y. Diketopiperazines from marine organisms. Chem. Biodivers., 2010, 7, 2809-2829.
7. Abderhalden, E.; Komm, E. The formation of diketopiperazines from polypeptides under various conditions. Z. Physiol. Chem., 1924, 139, 147-152.
8. Prasad, C. Bioactive cyclic dipeptides. Peptides, 1995, 16, 151-164.
9. Martins, M. B.; Carvalho, I. Diketopiperazines: Biological activity and synthesis. Tetrahedron, 2007, 63, 9923-9932.
10. Gruenewald, S.; Mootz, H. D.; Stehmeier, P.; Stachelhaus, T. In vivo production of artificial nonribosomal peptide products in the heterologous host Escherichia coli. Appl. Environ. Microbiol., 2004, 70, 3282-3291.
11. Schultz, A. W.; Oh, D.-C.; Carney, J. R.; Williamson, R. T.; Udwary, D. W.; Jensen, P. R.; Gould, S. J.; Fenical, W.; Moore, B. S. Biosynthesis and structures of cyclomarins and cyclomarazines, prenylated cyclic peptides of marine actinobacterial origin. J. Am. Chem. Soc., 2008, 130, 4507-4516.
12. Gondry, M.; Sauguet, L.; Belin, P.; Thai, R.; Amouroux, R.; Tellier, C.; Tuphile, K.; Jacquet, M.; Braud, S.; Courçon, M.; Masson, C.; Dubois, S.; Lautru, S.; Lecoq, A.; Hashimoto, S.; Genet, R.; Pernodet, J.-L. Cyclodipeptide synthases are a family of tRNA-dependent peptide bond-forming enzymes. Nat. Chem. Biol., 2009, 5, 414-420.
13. Bonnefonda, L.; Araib, T.; Sakaguchib, Y.; Suzukib, T.; Ishitania, R.; Nureki, O. Structural basis for nonribosomal peptide synthesis by an aminoacyl-tRNA synthetase paralog. Proc. Nat. Acad. Sci., U. S. A., www.pnas.org/cgi/doi/10.1073/pnas.1019480108. 2011.
14. Kanzaki, H.; Imura, D.; Nitoda, T.; Kawazu, K. Enzymatic conversion of cyclic dipeptides to dehydro derivatives that inhibit cell division. J. Biosci. Bioeng., 2000, 90, 86-89.
15. Kanoh, K.; Kohno, S.; Katada, J.; Takahashi, J.; Uno, I. (-)-Phenylahistin arrests cells in mitosis by inhibiting tubulin polymerization. J. Antibiot., 1999, 52, 134-141.
16. Sinha, S.; Srivastava, R.; De Clercq, E.; Singh, R. K. Synthesis and antiviral properties of arabino and ribonucleosides of 1, 3-dideazaadenine, 4-nitro-1, 3-dideazaadenine and diketopiperazine. Nucleosides Nucleotides Nucleic Acids, 2004, 23, 1815-1824.
17. Uhegbu, E. E.; Trischman, J. A. Abstracts of Papers, 229th National Meeting of the American Chemical Society, San Diego, CA, Mar 13-17, 2005; American Chemical Society: Washington, DC, 2005; CHED 1151.
18. Bolognesi ML, Ai Tran H. N.; Staderini, M.; Monaco, A.; López-Cobeñas, A.; Bongarzone, S.; Biarnés, X.; López-Alvarado, P.; Cabezas, N.; Caramelli, M.; Carloni, P.; Menéndez, J. C.; Legname, G. Discovery of a class of diketopiperazines as antiprion compounds. ChemMedChem, 2010, 5, 1324-1334.
19. Kwon, O. S.; Park, S. H.; Yun, B. S.; Pyun, Y. R.; Kim, C. J. Cyclo(dehydroala-L-Leu), an a-glucosidase inhibitor from Penicillium sp. F7Q6l4. J. Antibiot., 2000, 53, 954-958.
20. Song, M. K.; Hwang, I. K.; Rosenthal, M. J.; Harris, D. M.; Yamaguchi, D. T.; Yip, I; Go, V. L. W. Anti-hyperg lycemic activity of zinc plus cyclo (His-Pro) in genetically diabetic Goto-Kakizaki and aged rats. Exp. Biol. Med., 2003, 228, 1338-1345.
21. Asano, N. Glycosidase inhibitors: update and perspectives on practical use. Glycobiol, 2003, 13, 93R-104R.
22. Kilian, G.; Jamie, H.; Brauns, S. C. A.; Dyason, K.; Milne, P. J. Biological activity of selected tyro sine-containing 2, 5-diketopiperazines. Pharmazie, 2005, 60, 305-309.
23. Imamura, M.; Prasad, C. Cyclo (His-Pro) potentiates GABA/ethanol-mediated chloride uptake by neurosynap to somes. Peptides, 2003, 24, 445-448.
24. Lopez-Rodriguez, M. L.; Morcillo, M. J.; Fernandez, E.; Porras, E.; Orensanz, L.; Beneytez, M. E.; Manzanares, J.; Fuentes, J. A. Synthesis and structure-activity relationships of a new model of arylpiperazines. 5.1 Study of the physicochemical influence of the pharmacophore on 5-HT1A/r1-adrenergic receptor affinity: Synthesis of a new derivative with mixed 5-HT1A/D2 antagonist properties. J. Med. Chem., 2001, 44, 186-197.
25. Wyatt, P. G.; Allen, M. J.; Borthwick, A. D.; Davies, D. E.; Exall, A. M.; Hatley, R. J. D.; Irving, W. R.; Livermore, D. G.; Miller, N. D.; Nerozzi, F.; Sollis, S. L.; Szardenings, A. K. 2, 5-Diketopiperazines as potent and selective oxytocin antagonists 1: identification, stereochemistry and initial SAR. Bioorg. Med. Chem. Lett., 2005, 15, 2579-2582.
26. Liddle, J. Substituted diketopiperazines and their use as oxytocin antagonists. PCT Int. Appl. CODEN: PIXXD2;WO2005000840; A1 20050106, 2005.
27. Brooks, D. P. Substituted diketopiperazines for the treatment of benign prostatic hyperplasia. PCT Int. Appl. CODEN: PIXXD2; WO 2005000311; A1 20050106, 2005.
28. Folkes, A.; Roe, M. B.; Sohal, S.; Golec, J.; Faint, R.; Brooks, T.; Charlton, P. Synthesis and in vitro evaluation of a series of diketopiperazine inhibitors of plasminogen activator inhibitor-1. Bioorg. Med. Chem. Lett., 2001, 11, 2589-2592.
29. Wang, S.; Golec, J.; Miller, W.; Milutinovic, S.; Folkes, A.; Williams, S.; Brooks, T.; Hardman, K.; Charlton, P.; Wren, S.; Spencer, J. L-Cysteine based N-type calcium channel blockers: Structure-activity relationships of the C-terminal lipophilic moiety, and oral analgesic efficacy in rat pain models. Bioorg. Med. Chem. Lett., 2002, 12, 2367-2269.
30. McCleland, K.; Milne, P. J.; Lucieto, F. R.; Frost, C; Brauns, S. C; Van De Venter, M.; Du Plessis, J.; Dyason, K. An investigation into the biological activity of the selected histidine-containing diketopiperazines cyclo(His-Phe) and cyclo(His-Tyr). J. Pharm. Pharmacol., 2004, 56, 1143-1153.
31. Cheng, Y; Manwell, J. Diketopiperazine derivatives to inhibit thrombin. U.S. Pat. Appl. Publ. 130, 281, 2005; Chem. Abstr 2005, 142, 411381.
32. Walter, R.; Ritzmann, R. F.; Bhargava, H. N; Flexner, L. B. Prolyl-leucyl-glycinamide, cyclo(leucylglycine), and derivatives block development of physical dependence on morphine in mice. Proc. Natl. Acad. Sci. USA, 1979, 76, 518-520.
33. Withers, H.; Swift, S.; Williams, P. Quorum sensing as an integral component of gene regulatory networks in Gram-negative bacteria. Curr. Opin. Microbiol, 2001, 4, 186-193.
34. Abraham, W.-R. Controlling Gram-negative pathogenic bacteria by interfering with their biofilm formation. Drug Des. Rev. 2005, 2, 13-33.
35. Ichikawa, S.; Matsuda, A. Chemistry and structure-activity relationship of antibacterial nucleoside natural products. Nucleic Acids Symp. Ser. (Oxf)., 2008, 52, 77-78.
36. Rhee, K.-H.; Choi, K.-H.; Kim, C.-J.; Kim, C.-H. Identification of Streptomyces sp. AMLK-335 producing antibiotic substance inhibitory to VRE (vancomycin-resistant enterococci). J. Microbiol. Biotechnol, 2001, 11, 469-474.
37. Rhee, K.-H. Isolation and characterization of Streptomyces sp. KH-614 producing anti-VRE (vancomycin-resistant enterococci) antibiotics. J. Gen. Appl. Microbiol., 2002, 48, 321-327.
38. Rhee, K.-H. Cyclic dipeptides exhibit synergistic, broad spectrum antimicrobial effects and have anti-mutagenic properties. Int. J. Antimicrob. Agents, 2004, 24, 423-427.
39. Furtadoa, N. A. J. C; Pupoa, M. T.; Carvalhoa, I; Campoa, V L.; Duarteb, M. C. T.; Bastos, J. K. Diketopiperazines produced by an Aspergillus fumigatus Brazilian strain. J. Braz. Chem. Soc, 2005, 16, 1448-1453.
40. Huberman, L.; Gollop, N; Mumcuoglu, K. Y; Breuer, E.; Bhusare, S. R.; Shai, Y; Galun, R. Antibacterial substances of low molecular weight isolated from the blowfly, Lucilia sericata. Med. Vet. Entomol, 2007, 21, 127-131.
41. Li, H.; Lee, B. C; Kim, T. S.; Bae, K. S.; Hong, J.; Choi, S. H.; Bao, B.; Jung, J. H. Bioactive cyclic dipeptides from a marine sponge-associated bacterium, Psychrobacter sp. Biomolecules Ther., 2008, 16, 356-363.
42. Smaoui, S.; Mellouli, L.; Lebrihi, A.; Coppel, Y; Fguira, L. F B.; Mathieu, F. Purification and structure elucidation of three naturally bioactive molecules from the new terrestrial Streptomyces sp. TN1 7 strain. Nat. Prod. Res., 2011, 25, 806-814.
43. Kozlovsky, A. G.; Vinokurova, N. G.; Adanin, V M.; Burkhardt, G.; Dahse, H.-M.; Gräfe, U. New diketopiperazine alkaloids from Penicillium fellutanum. J. Nat. Prod., 2000, 63, 698-700.
44. Lee, K.-H.; Kim, G.-W.; Rhee, K.-H. Identification of Streptomyces sp. KH29, which produces an antibiotic substance possessing an inhibitory activity against multidrug-resistant Acinetobacter baumannii. J. Microbiol. Biotechnol., 2010, 20, 1672-1676.
45. Kalinovskaya N. I.; Kalinovsky, A. I.; Romanenko, L. A.; Dmitrenok, P. S.; Kuznetsova, T. A. New angucyclines and antimicrobial diketopiperazines from the marine mollusk-derived actinomycete Saccharothrix espanaensis An 113. Nat. Prod. Commun., 2010, 5, 597-602.
46. Fdhila, F.; Vazquez, V.; Sanchez, J. L.; Riguera, R. DD- Diketopiperazines: Antibiotics active against Vibrio anguillarum isolated from marine bacteria associated with cultures of Pecten maximus. J. Nat. Prod., 2003, 66, 1299-1301.
47. Atkin, C. L.; Neilands, J. B. Rhodotorulic acid, a diketopiperazine dihydroxamic acid with growth-factor activity. I. Isolation and characterization. Biochem., 1968, 7, 3734-3739.
48. Sugie, Y.; Hirai, H.; Inagaki, T.; Ishiguro, M.; Kim, Y.-J.; Kojima, Y.; Sakakibara, T.; Sakemi, S.; Sugiura, A.; Suzuki, Y.; Brennan, L.; Duignan, J.; Huang, L. H.; Sutcliffe, J.; Kojima, N. A new antibiotic CJ-17, 665 from Aspergillus ochraceus. J. Antibiot., 2001, 54, 911-916.
49. Allen, Jr, C. M. Biosynthesis of echinulin. Isoprenylation of cyclo-L-alanyl-L-tryptophanyl. Biochem., 1972, 11, 2154-2160.
50. Kanokmedhakul, S.; Kanokmedhakul, K.; Phonkerd, N.; Soytong, K.; Kongsaeree, P.; Suksamrarn, A. Antimycobacterial anthraquinone-chromanone compound and diketopiperazine alkaloid from the fungus Chaetomium globosum KMITL-N0802. Planta Med., 2002, 68, 834-836.
51. Kopp-Holtwiesche, B.; Rehm, H. J. Antimicrobial action of roquefortine. J. Environ. Pathol. Toxicol. 1990, 10, 41-44.
52. Clark, B.; Capon, R. J.; Lacey, E.; Tennant, S.; Gill, J. H. Roquefortine E, a diketopiperazine from an Australian isolate of Gymnoascus reessii. J. Nat. Prod. 2005, 68, 1661-1664.
53. Schultz, A. W.; Oh, D.-C.; Carney, J. R.; Williamson, R. T.; Udwary, D. W.; Jensen, P. R.; Gould, S. J.; Fenical, W.; Moore, B. S. Biosynthesis and structures of cyclomarins and cyclomarazines, prenylated cyclic peptides of marine actinobacterial origin. J. Am. Chem. Soc. 2008, 130, 4507-4516.
54. Koolen, H. H.; Soares, E. R.; da Silva, F. M.; Lima de Souza, A. Q.; de Medeiros, L. S.; Filho, E. R.; de Almeida, R. A.; Ribeiro, I. A.; do Pessoa, C.; de Morais, M. O.; da Costa, P. M.; de Souza, A. D. An antimicrobial diketopiperazine alkaloid and co-metabolites from an endophytic strain of Gliocladium isolated from Strychnos cf. toxifera. Nat. Prod. Res., 2011 Nov 25. [Epub ahead of print]
55. Fukushima, K.; Yazawa, K.; Arai, T. Biological activities of albonoursin. J. Antibiot., 1973, 26, 175-176.
56. Kanzaki, H.; Yanagisawa, S.; Nitoda, T. Biosynthetic intermediates of the tetradehydro cyclic dipeptide albonoursin produced by Streptomyces albulus KO-23. J. Antibiot., 2000, 53, 1257-1264.
57. Jiang, C. S.; Guo, Y. W. Epipolythiodioxopiperazines from fungi: chemistry and bioactivities. Mini Rev. Med. Chem., 2011, 11, 728-745.
58. Waring, P.; Beavert, J. Gliotoxin and related epipolythiodioxopiperazines. Gen. Pharmac., 1996, 27, 1311-1316.
59. Gardiner, D. M.; Waring, P.; Howlett, B. J. The epipolythiodioxopiperazine (ETP) class of fungal toxins: distribution, mode of action, functions and biosynthesis. Microbiology, 2005, 151, 1021-1032.
60. Boudart, G. Antibacterial activity of sirodesmin PL phytotoxin: Application to the selection of phytotoxin-deficient mutants. Appl. Environ. Microbiol., 1989, 55, 1555-1559.
61. Poiret, B.; Kollmann, A.; Bousquet, J.-F. Activités antifongiques de la sirodesmine PL et de deux analogues naturels isolés de Phoma lingam (Tode) Desm. Action antagoniste du zinc. Agronomie, 1985, 5, 533-538.
62. Guimarães, D. O.; Borges, W. S.; Vieira, N. J.; de Oliveira, L. F.; da Silva, C. H. T. P.; Lopes, N. P.; Dias, L. G.; Durán-Patrón, R.; Collado, I. G.; Pupo, M. T. Diketopiperazines produced by endophytic fungi found in association with two Asteraceae species. Phytochemistry, 2010, 71, 1423-1429.
63. Funabashi, Y,; Horiguchi, T.; Iinuma, S.; Tanida, S.; Harada, S. TAN-1496 A, C and E, diketopiperazine antibiotics with inhibitory activity against mammalian DNA topoisomerase I. J. Antibiot., 1994, 47, 1202-1218.
64. Kamiya, T.; Maeno, S.; Hashimoto, M.; Mine Y. Bicyclomycin, a new antibiotic. II. Structural elucidation and acyl derivatives. J. Antibiot. 1972, 25, 576-581.
65. Nishida, M.; Mine, Y.; Matsubara, T.; Goto, S.; Kuwabara, S. Bicyclomycin, a new antibiotic. III. In vitro and in vivo antimicrobial activity. J. Antibiot., 1972, 25, 582-593.
66. Kohn, H.; Widger, W. The molecular basis for the mode of action of bicyclomycin. Curr. Drug Targets Infect. Disord., 2005, 5, 273-295.
67. Muller, B. W.; Zak, O.; Kump, W.; Tosch, W.; Wacker, O. Semisynthetic bicyclomycin derivatives: preparation and antibacterial evaluation. J. Antibiot. 1979, 32, 689-705.
68. Williams, R. M.; Durham, C. A. Bicyclomycin: synthetic, mechanistic, and biological studies. Chem. Rev., 1988, 88, 511-540.
69. Park, H.; Zhang, Z.; Zhang, X.; Widger, W. R.; Kohn, H. Role of the C(5)-C(5a) exomethylene group in bicyclomycin: Synthesis, structure, and biochemical and biological properties. J. Org. Chem., 1996, 61, 7764-7776.
70. Santillan, Jr., A.; Park H.;Zhang X.;Lee O.-S.;Widger W. R.;Kohn H. Role of the [4.2.2] bicyclic unit in bicyclomycin: Synthesis, structure, chemical, biochemical, and biological properties. J. Org. Chem. 1996, 61, 7756-7763.
71. Park, H.; Zhang, X.; Widger, W. R.; Kohn H. Role of the C(1) triol group in bicyclomycin: Synthesis and biochemical and biological properties. J. Org. Chem., 1996, 61, 7750-7755.
72. Williams, R. M.; Armstrong, R. W.; Dung, J. S. Synthesis and antimicrobial evaluation of bicyclomycin analogues. J. Med. Chem., 1985, 28, 733-740.
73. Fusetani, N. Antifungal peptides in marine invertebrates. Invertebrate Survival J., 2010, 7, 53-66.
74. Houston, D. R.; Synstad, B.; Eijsink, V. G. H.; Stark, M. J. R.; Eggleston, I. M.; van Aalten, D. M. F. Structure-based exploration of cyclic dipeptide chitinase inhibitors. J. Med. Chem., 2004, 47, 5713-5720.
75. Byun, H.-G.; Zhang, H.; Mochizuki, M.; Adachi, K.; Shizuri, Y.; Lee, W.-J.; Kim, S.-K. Novel antifungal diketopiperazine from marine fungus. J. Antibiot. 2003, 56, 102-106.
76. Ström, K.; Sjögren, J.; Broberg, A.; Schnürer, J. Lactobacillus plantarum MiLAB 393 produces the antifungal cyclic dipeptides cyclo(L-Phe-L-Pro) and cyclo(L-Phe-trans-4-OH-L-Pro) and 3-phenyllactic acid. Appl. Environ. Microbiol, 2002, 68, 4322-4327.
77. Yang, E. J.; Chang H. C. Purification of a new antifungal compound produced by Lactobacillus plantarum AF1 isolated from kimchi. Int. J. Food Microbiol., 2010, 139, 56-63.
78. Lorenz, P; Jensen, P. R.; Fenical, W. Mactanamide, A new fungistatic diketopiperazine produced by a marine Aspergillus sp. Nat. Prod. Lett., 1998, 12, 55-60.
79. Hirsch S.; Miroz, A.; McCarthy, P.; Kashman, Y Etzionin, a new antifungal metabolite from a red sea tunicate. Tetrahedron Lett., 1989, 30, 4291-4294.
80. Yonezawa, K.; Yamada, K.; Kouno, I. New diketopiperazine derivatives isolated from sea urchin-derived Bacillus sp. Chem. Pharm. Bull. (Tokyo), 2011, 59(1), 106-108.
81. Coleman, J. J.; Ghosh, S.; Okoli, I; Mylonakis, E. Antifungal activity of microbial secondary metabolites. PLoS ONE, 2011, 6, e25321. doi:10.1371/journal.pone.0025321.
82. Strunz, G. M.; Kakushima, M.; Stillwell, M. A.; Heissner, C. J. Hyalodendrin: A new fungitoxic epidithiodioxopiperazine produced by a Hyalodendron species. J. C. S. Perkin I, 1973, 2600-2602.
83. Michel, K. H.; Chaney, M. O.; Jones, N. D.; Hoehn, M. M.; Nagarajan, R. Epipolythiopiperazinedione antibiotics from Penicillium turbatum. J. Antibiot. (Tokyo), 1974, 27, 57-64.
84. Nagarajan, R.; Huckstep, L. L.; Lively, D. H.; DeLong D. C; Marsh, M. M.; Neuss, N. Aranotin and related metabolites from Avachniofus aureus. I. Determination of structure. J. Am. Chem Soc, 1968, 90, 2980-2982.
85. Trown, P. W.; Lindh, H. F.; Milstrey, K. P.; Gallo, V. M.; Mayberry, B. R.; Lindsay, H. L.; Miller, P. A. LL-S88a, an antiviral substance produced by Aspergillus terreus. Antimicrob. Agents Chemother. (Bethesda), 1968, 8, 225-228.
86. Cosulich, D. B; Nelson, N. R.; van den Hende, J. H. Crystal and molecular structure of LL-SS8a an antiviral epidithiapiperazinedione derivative from Aspergillus terreus. J. Am. Chem. Soc, 1968, 90, 6519-6521.
87. Wang, W.; Wang, Y; Tao, H.; Peng, X.; Liu, P.; Zhu, W. Cerebrosides of the halotolerant fungus Alternaria raphani isolated from a sea salt field. J. Nat. Prod., 2009, 72, 1695-1698.
88. Trown, P. W. Antiviral activity of N, N'- dimethylepidithiapiperazinedione, a synthetic compound related to the gliotoxins, LL-S88 a and 13, chetomin and the sporidesmins. Biochem. Biophys. Res. Commun., 1968, 33, 402-407.
89. Rightsel, W. A.; Schneider, H. G.; Sloan, B. J.; Graf, P. R.; Miller, F. A.; Bartz, Q. R.; Ehrlich, J. Antiviral activity of gliotoxin and gliotoxin acetate. Nature, 1964, 204, 1333-1334.
90. Trown, P. W.; Bilello, J. A. Mechanism of action of gliotoxin: Elimination of activity by sulfhydryl compounds. Antimicrob. Agents Chemother., 1972, 2, 261-266.
91. Salazar-Mather, T. P.; Orange, J. S.; Biron, C. A. Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1a (MIP-1 a)-dependent pathways. J. Exp. Med., 1998, 187, 1-14.
92. Maeda, K.; Yoshimura, K.; Shibayama, S.; Habashita, H.; Tada, H.; Sagawa, K.; Miyakawa, T.; Aoki, M.; Fukushima, D.; Mitsuya, H. Novel low molecular weight spirodiketopiperazine derivatives potently inhibit R5 HIV-1 infection through their antagonistic effects on CCR5. J. Biol. Chem., 2001, 276, 35194-35200.
93. Habashita, H.; Kokubo, M.; Hamano, S.; Hamanaka, N.; Toda, M.; Shibayama, S.; Tada, H.; Sagawa, K.; Fukushima, D.; Maeda, K.; Mitsuya, H. Design, synthesis, and biological evaluation of the combinatorial library with a new spirodiketopiperazine scaffold. Discovery of novel potent and selective low-molecular-weight CCR5 antagonists. J. Med. Chem., 2006, 49, 4140-4152.
94. Nishizawa, R.; Nishiyama, T; Hisaichi, K.; Matsunaga, N; Minamoto, C; Habashita, H.; Takaoka, Y; Toda, M.; Shibayama, S.; Tada, H.; Sagawa, K.; Fukushima, D.; Maeda, K.; Mitsuya, H. Spirodiketopiperazine-based CCR5 antagonists: Lead optimization from biologically active metabolite. Bioorg. Med. Chem. Lett., 2007, 17, 727-731.
95. Nishizawa, R.; Nishiyama, T.; Hisaichi, K.; Hirai, K.; Habashita, H.; Takaoka, Y; Tada, H.; Sagawa, K.; Shibayama, S.; Maeda, K.; Mitsuya, H.; Nakai, H.; Fukushima, D.; Toda, M. Spirodiketopiperazine-based CCR5 antagonists: Improvement of their pharmacokinetic profiles. Bioorg. Med. Chem. Lett., 2010, 20, 763-766.
96. Nishizawa, R.; Nishiyama, T.; Hisaichi, K.; Hirai, K.; Habashita, H.; Takaoka, Y.; Tada, H.; Sagawa, K.; Shibayama, S.; Maeda, K.; Mitsuya, H.; Nakai, H.; Fukushima, D.; Toda, M. Discovery of orally available spirodiketopiperazine-based CCR5 antagonists. Bioorg. Med. Chem., 2010, 18, 5208-5223.
97. Maeda, K.; Nakata, H.; Koh, Y.; Miyakawa, T.; Ogata, H.; Takaoka, Y.; Shibayama, S.; Sagawa, K.; Fukushima, D.; Moravek, J.; Koyanagi, Y.; Mitsuya, H. Spirodiketopiperazine-based CCR5 inhibitor which preserves CC-chemokine/CCR5 interactions and exerts potent activity against R5 human immunodeficiency virus type 1 in vitro. J. Virol., 2004, 78, 8654-8662.
98. Nishizawa, R.; Nishiyama, T.; Hisaichi, K.; Minamoto, C.; Matsunaga, N.; Takaoka, Y.; Nakai, H.; Jenkinson, S.; Kazmierski, W. M.; Tada, H.; Sagawa, K.; Shibayama, S.; Fukushima, D.; Maeda, K.; Mitsuya, H. Spirodiketopiperazine-based CCR5 antagonist: discovery of an antiretroviral drug candidate. Bioorg. Med. Chem. Lett., 2011, 21(4), 1141-1145.
99. Watts, K. R.; Ratnam, J.; Ang, K.-H.; Tenney, K.; Compton, J. E.; McKerrow, J.; Crews, P. Assessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi. Bioorg. & Med. Chem., 2010, 18, 2566-2574.
100. Costerton, J. W.; Stewart, P. S.; Greenberg, E. P. Bacterial biofilms: A common cause of persistent infections. Science, 1999, 284, 1318-1322.
101. O' Toole, G.; Kaplan, H. B.; Kolter, R. Biofilm formation as microbial development. Ann. Rev. Microbiol., 2000, 54, 49-79.
102. Cegelski, L.; Marshall, G. L.; Eldridge, G. L.; Hultgren, S. J. The biology and future prospects of antivirulence therapies. Nat. Rev. Microbiol., 2008, 6, 17-27.
103. Davies, D. Understanding biofilm resistance to antibacterial agents. Nat. Rev. Drug Discov., 2003, 2, 114-122.
104. Hentzer, M.; Givskov, M. Pharmacological inhibition of quorum sensing for the treatment of chronic bacterial infections. J. Clin. Invest., 2003, 11 2, 1300-1307.
105. Taga, M. E.; Bassler, B. L. Chemical communication among bacteria. Proc. Natl. Acad. Sci. U. S. A, 2003, 100, 14549-14554.
106. Hentzer, M.; Eberl, L.; Givskov, M. Transcriptome analysis of Pseudomonas aeruginosa biofilm development: anaerobic repiration and iron limitation. Biofilms, 2005, 2, 37-61.
107. Bjarnsholt, T and Givskov, M. Quorum sensing inhibitory drugs as the next generation of anti-microbial compounds: Will it be worth the effort? Curr. Infect. Dis. Rep., 2008, 1, 22-28.
108. Jensen, P.O; Bjarnsholt, T; Phipps, R.; Rasmussen, T. B.; Calum, H.; Christoffersen, L.; Moser, C.; Williams, P.; Pressler, T.; Givskov, M. Hoiby, N. Rapid necrotic killing of polymorphonuclear leukocytes is caused by quorum-sensing-controlled production of rhamnolipid by Pseudomonas aeruginosa. Microbiol., 2007, 153, 1329-1338.
109. Abraham, W.-R. Controlling the biofilm formation of Gram-positive pathogenic bacteria. Curr. Med. Chem., 2006, 13, 1509-1524.
110. Götz, F. Staphylococcus and biofilms. Mol. Microbiol., 2002, 43, 1367-1378.
111. Yarwood, J. M.; Bartels, D. J.; Volper, E. M.; Greenberg, E.P. Quorum sensing in Staphylococcus aureus biofilms, J. Bacteriol. 2004, 186, 1838-1850.
112. Cirioni, O.; Giacometti, A.; Ghiselli, R.; Bergnach, C.; Orlando, F.; Mocchegiani, F.; Silvestri, C.; Licci, A.; Skerlavaj, B.; Zanetti, M.; Saba, V.; Scalise, G. Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. Peptides, 2006, 27, 2104-2110.
113. Mitova, M.; Tommonaro, G.; Hentschel, U.; Müller, W. E. G.; De Rosa, S. Exocellular cyclic dipeptides from a Ruegeria strain associated with cell cultures of Suberites domuncula. Mar. Biotechnol., 2004, 6, 95-103.
114. Park, H. B.; Kwon, H. C.; Lee, C.-H.; Yang, H. Ok. Glionitrin A, an antibiotic-antitumor metabolite derived from competitive interaction between abandoned mine microbes. J. Nat. Prod., 2009, 72, 248-252.
115. Trischman, J. A.; Oeffner, R. E.; de Luna, M. G.; Kazaoka, M. Competitive induction and enhancement of indole and a diketopiperazine in marine bacteria. Mar. Biotechnol., 2004, 6, 215-220.
116. Ortiz-Castro, R.; Díaz-Pérez, C.; Martínez-Trujillo, M.; del Río, R. E.; Campos-García, J.; López-Bucio, J. Transkingdom signaling based on bacterial cyclodipeptides with auxin activity in plants. Proc.Natl. Acad. Sci. U. S. A., 2011, 108(17), 7253-7258.
117. Holden, M.T.G.; Chhabra, S.R.; de Nys, R.; Stead, P.; Bainton, N.J.; Hill, P.J.; Manefeld, M.; Kumar, N.; Labatte, M.; England, D.; Rice, S.; Givskov, M.; Salmond, G.P.C.; Stewart, G.S.A.B.; Bycroft, B.W.; Kjelleberg, S.; Williams, P. Quorum-sensing cross talk: isolation and chemical characterization of cyclic dipeptides from Pseudomonas aeruginosa and other Gram-negative bacteria. Mol. Microbiol., 1999, 33, 1254-1266.
118. Degrassi, G.; Aguilar, C.; Bosco, M.; Zahariev, S.; Pongor, S.; Venturi, V. Plant growth-promoting Pseudomonas putida WCS358 produces and secretes four cyclic dipeptides: Cross-talk with quorum sensing bacterial sensors. Curr. Microbiol. 2002, 45, 250-254.
119. Wang, J.-H.; Quan, C.-S.; Qi, X.-H.; Xin, L.; Fan, S.-D. Determination of diketopiperazines of Burkholderia cepacia CF-66 by gas chromatography-mass spectrometry. Anal. Bioanal. Chem., 2010, 396, 1773-1779.
120. Park, D. K.; Lee, K. E.; Baek, C. H.; Kim, I. H.; Kwon, J. H.; Lee, W. K.; Lee, K. H.; Kim, B. S.; Choi, S. H.; Kim, K. S. Cyclo(Phe-Pro) modulates the expression of ompU in Vibrio spp. J. Bacteriol. 2006, 188, 2214-2221.
121. Tommonaro, G.; Abbamondi, G.R.; Iodice, C.; Tait, K.; De Rosa, S. Diketopiperazines produced by the halophilic Archaeon, Haloterrigena hispanica, activate AHL bioreporters. Microb. Ecol. 2011, DOI: 10.1007/s00248-011-9980-y.
122. Ryan, R. P.; Dow, J. M. Diffusible signals and interspecies communication in bacteria. Microbiol. 2008, 154, 1845-1858.
123. Li, J.; Wang, W.; Xu, S. X.; Magarvey, N. A.; McCormick, J. K. Lactobacillus reuteri-produced cyclic dipeptides quench agr-mediated expression of toxic shock syndrome toxin-1 in staphylococci. Proc. Natl. Acad. Sci. U. S. A., 2011, 108, 3360-3365.
124. Campbell, J.; Lin, Q.; Geske, G. D.; Blackwell, H. E. New and unexpected insights into the modulation of LuxR-type quorum sensing by cyclic dipeptides. ACS Chem. Biol., 2009, 4, 1051-1059.
125. Estrela, A. B.; Heck, M. G.; Abraham, W.-R. Novel approaches to control biofilm infections. Curr. Med. Chem., 2009, 16, 1512-1530.
126. Campbell, J.; Blackwell, H. E. Efficient construction of diketopiperazine macroarrays through a cyclative-cleavage strategy and their evaluation as luminescence inhibitors in the bacterial symbiont Vibrio fischeri. J. Comb. Chem., 2009, 11(6), 1094-1099.
127. Antia, B. S.; Aree, T.; Kasettrathat, C.; Wiyakrutta, S.; Ekpa, O. D.; Ekpe, U. J.; Mahidol, C.; Ruchirawat, S.; Kittakoop, P. Itaconic acid derivatives and diketopiperazine from the marine-derived fungus Aspergillus aculeatus CRI322-03. Phytochemistry, 2011, 72, 816-820.
128. Larsen, T.O., Frisvad, J.C., Jensen, S.R. Aurantiamine, a diketopiperazine from two varieties of Penicillium aurantiogriseum. Phytochemistry, 1992, 31, 1613-1615.
129. Holzapfel, C.W.; Marsh, J.J. Isolation and structure of viridamine, a new nitrogenous metabolite of Penicillium viridicatum Westling. South Afr. J. Chem. 1977, 30, 197-204.
130. López-Gresa, M. P.; Cabedo, N.; González-Mas, M. C.; Ciavatta, M. L.; Avila, C.; Primo, J. Terretonins E and F, inhibitors of the mitochondrial respiratory chain from the marine-derived fungus Aspergillus insuetus. J. Nat. Prod., 2009, 72(7), 1348-1351.
131. Ishikawa, K.; Hosoe, T.; Itabashi, T.; Wakana, D.; Takizawa, K.; Yaguchi, T.; Kawai, K. Novoamauromine and ent-cycloechinulin: Two new diketopiperazine derivatives from Aspergillus novofumigatus. Chem. Pharm. Bull. 2010, 58, 717-719.
132. Park, Y. C.; Gunasekera, S. P.; Lopez, J. V.; McCarthy, P. J.; Wright, A. E. Metabolites from the marine-derived fungus Chromocleista sp. isolated from a deep-water sediment sample collected in the Gulf of Mexico. J. Nat. Prod. 2006, 69, 580-584.
133. Rukachaisirikul, V.; Khamthong, N.; Sukpondma, Y.; Phongpaichit, S.; Hutadilok-Towatana, N.; Graidist, P.; Sakayaroj, J.; Kirtikara, K. Cyclohexene, diketopiperazine, lactone and phenol derivatives from the sea fan-derived fungi Nigrospora sp. PSU-F11 and PSU-F12. Arch. Pharm. Res., 2010, 33, 375-380.
134. Kolodkin-Gal, I.; Romero, D.; Cao, S.; Clardy, J.; Kolter, R.; Losick, R. D-Amino acids trigger biofilm disassembly. Science, 2010, 328, 627-629.
135. Hochbaum, A. I.; Kolodkin-Gal, I.; Foulston, L.; Kolter, R.; Aizenberg, J.; Losick, R. Inhibitory effects of D-amino acids on Staphylococcus aureus biofilm development. J. Bacteriol., 2011, 193, 5616-5622.
136. Deppermann, N.; Prenzel, A. H. G. P.; Beitat, A.; Maison, W. Synthesis of proline-based diketopiperazine scaffolds. J. Org. Chem., 2009, 74, 4267-4271.
137. Macedo, A. J.; Abraham, W.-R. Can infectious biofilms be controlled by blocking bacterial communication? Med. Chem., 2009, 5, 517-528.